Imbio PHA (4.0.0) vs AI-ECG Tracker

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Imbio (a subsidiary of 4DMedical)
VS
by Carewell Health

AI Verdict

Tool A focuses on analyzing CT pulmonary angiogram scans to assess cardiac structures for conditions like pulmonary embolism and hypertension. In contrast, Tool B specializes in AI-powered auto-diagnosis of 12-lead ECG data for a broad spectrum of cardiac abnormalities, including arrhythmias and myocardial infarction. While both are cardiology AI tools, they address different diagnostic needs using distinct medical imaging and signal data.

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA (4.0.0) if your clinical workflow requires automated, quantitative analysis of CT pulmonary angiogram (CTPA) scans. This tool is ideal for radiologists and cardiologists who need to rapidly assess right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension directly from imaging data.

View Imbio PHA (4.0.0) →

Choose AI-ECG Tracker if…

Choose AI-ECG Tracker if your primary need is rapid, AI-powered auto-analysis and diagnosis of 12-lead ECG data for a broad spectrum of cardiac abnormalities. This solution is best suited for cardiologists and emergency medicine professionals who require high-accuracy identification of conditions like arrhythmias, myocardial ischemia, and ventricular hypertrophy to support quick clinical decision-making.

View AI-ECG Tracker →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Imbio PHA (4.0.0) AI-ECG Tracker
Deployment Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities.
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Imbio PHA (4.0.0)

Imbio PHA emphasizes seamless integration with native DICOM tools and existing radiology workflows, generating annotated DICOM images and PDF reports. This approach minimizes disruption to current clinical practices. While AI-ECG Tracker offers rapid diagnosis and a comprehensive system, its dedicated workstation and client might introduce new workflow elements.

Clinical Value

AI-ECG Tracker

AI-ECG Tracker boasts high accuracy (over 95%) for common cardiac abnormalities and provides comprehensive diagnostic support for 16 cardiac classifications and 104 ECG diagnostic classifications. This broad coverage offers significant clinical utility across a wide range of cardiac conditions. Imbio PHA, while valuable for specific conditions like pulmonary embolism and hypertension, has a more focused application.

Pricing & Value

Tie

Neither Imbio PHA nor AI-ECG Tracker provides publicly available pricing information. Without details on cost or specific return on investment metrics, it is impossible to conduct a head-to-head comparison of their pricing and value propositions.

Enterprise Readiness

Imbio PHA (4.0.0)

Imbio PHA explicitly states it is HIPAA compliant, with third-party certification by Compliancy Group, and offers flexible deployment options including Cloud, Enterprise (on-premise), or via partners. AI-ECG Tracker's compliance claims are less definitive, using terms like 'likely' for BAA and HIPAA compliance, making Tool A a more robust choice for enterprise environments.

Innovation

AI-ECG Tracker

AI-ECG Tracker is recognized as a pioneer in applying AI to ECG auto-diagnosis and was the first Chinese innovative medical device in the AI ECG field to receive FDA clearance. Its comprehensive support for 104 ECG diagnostic classifications demonstrates a broad and impactful innovative scope within its domain. While Imbio PHA's application of AI to CTPA for specific cardiac measurements is also innovative, Tool B's pioneering status and extensive diagnostic capabilities give it a slight edge.

Support & Docs

Tie

The provided structured facts and web searches do not offer sufficient information regarding the availability, quality, or scope of support services and documentation for either Imbio PHA or AI-ECG Tracker. Therefore, a definitive winner cannot be determined for this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Imbio PHA (4.0.0) AI-ECG Tracker
Name Imbio PHA (4.0.0) AI-ECG Tracker
Company Imbio (a subsidiary of 4DMedical) Shenzhen Carewell Electronics Co.
Description Imbio PHA (4.0.0) is an FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. Shenzhen Carewell Electronics Co., a subsidiary of Lepu Medical, is a pioneer in applying artificial intelligence technology to ECG auto-diagnosis, distributing innovative AI medical devices to over 100 countries.
Key Features Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios; Utilizes artificial intelligence algorithms for anatomical identification and measurement; Generates annotated DICOM images; Provides summary reports in PDF format; Integrates with native DICOM tools and workflows; Rapid, fully-automated assessment (typically in minutes). AI-powered ECG auto-analysis and diagnosis; High accuracy (over 95%) for common cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction; Supports 12-lead ECG data collection; AI-ECG Workstation with powerful GPU for fast computing; Web-based Management Portal for organization settings, security, and task management; Window-based professional ECG diagnostic client for review, measurement, annotation, and report generation; Rapid diagnosis in approximately 3 seconds; Comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications.
Data Export DICOM format for annotated images and PDF for summary reports. Not specified
Specialties Cardiology, Pulmonology, Radiology Cardiology, Emergency Medicine
Languages Arabic, Dutch, English, French, German, Italian, Portuguese, Russian, Spanish. Not specified

Videos

Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and AI-ECG Tracker.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio PHA (4.0.0) is designed to analyze CT pulmonary angiogram (CTPA) scans to measure cardiac structures. In contrast, the AI-ECG Tracker focuses on analyzing 12-lead ECG data for auto-diagnosis of cardiac abnormalities.
Imbio PHA (4.0.0) aids in assessing potential right ventricular dilation and assists in the diagnosis and risk stratification of pulmonary embolism and hypertension from CTPA scans. The AI-ECG Tracker provides AI-powered auto-analysis and diagnosis for a wide range of common cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction from ECG data.
Imbio PHA (4.0.0) generates annotated DICOM images and summary reports in PDF format, integrating with native DICOM tools and workflows. The AI-ECG Tracker provides a Windows-based professional ECG diagnostic client for review, measurement, annotation, and report generation, along with a web-based management portal for organizational settings and task management.
Imbio PHA (4.0.0) offers rapid, fully-automated assessment typically in minutes. The AI-ECG Tracker provides a rapid diagnosis in approximately 3 seconds.
AI Tool Finder
AI-powered search. Results may not be comprehensive.